Gary Ingenito - 27 Dec 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Medical Officer
Signature
/s/ Gary Ingenito
Issuer symbol
CPRX
Transactions as of
27 Dec 2022
Net transactions value
$0
Form type
4
Filing time
29 Dec 2022, 15:48:06 UTC
Previous filing
08 Dec 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +93,000 +10% $0.000000 1,007,000 27 Dec 2022 Common Stock 93,000 $18.59 Direct F1
transaction CPRX Restricted Stock Units Award $0 +27,000 +2.7% $0.000000 1,034,000 27 Dec 2022 Common Stock 27,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.